Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ayoub

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|October 12, 2022
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Journal of Travel Medicine|May 29, 2021
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two dosesLaith J Abu-Raddad, Hiam Chemaitelly, Hadi M Yassine, et al.
Eclinicalmedicine|May 3, 2021
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyLaith J Abu-Raddad, Hiam Chemaitelly, Peter Coyle, et al.
JAMA|November 1, 2021
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Communications Medicine|July 2, 2025
Immune histories and natural infection protection during the omicron eraHiam Chemaitelly, Houssein H Ayoub, Niklas Bobrovitz, et al.
Scientific Reports|March 19, 2021
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort studyMai A Mahmoud, Houssein H Ayoub, Peter Coyle, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
The New England Journal of Medicine|October 12, 2022
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Journal of Travel Medicine|May 29, 2021
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two dosesLaith J Abu-Raddad, Hiam Chemaitelly, Hadi M Yassine, et al.
Eclinicalmedicine|May 3, 2021
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacyLaith J Abu-Raddad, Hiam Chemaitelly, Peter Coyle, et al.
JAMA|November 1, 2021
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Communications Medicine|July 2, 2025
Immune histories and natural infection protection during the omicron eraHiam Chemaitelly, Houssein H Ayoub, Niklas Bobrovitz, et al.
Scientific Reports|March 19, 2021
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort studyMai A Mahmoud, Houssein H Ayoub, Peter Coyle, et al.
Pageof 13